Pharmacy Market BUZZ

Market News, Products, Services, and Trends


Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. News & Announcements

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.

Pharmacy Press Release

November 19, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

November 15, 2021 | Press Releases

Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

November 9, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Carmustine for Injection, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


asembia must see

October 25, 2021 | Must-See Exhibits & Booths

Must See Booths: Asembia Specialty Summit 2021 - Dr. Reddy's Laboratories

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

September 3, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr reddy

August 6, 2021 | Product Awareness

You make Promises. We help you keep them.

Posted by RXinsider Staff RXinsider Staff


Dr reddy

July 1, 2021 | Product Awareness

You make Promises. We help you keep them.

Posted by RXinsider Staff RXinsider Staff


press release

June 30, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr. Reddy's

May 17, 2021 | Product Awareness

You make Promises. We help you keep them. [VIDEO]

Posted by RXinsider Staff RXinsider Staff


press release

May 14, 2021 | Product Awareness

Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

April 7, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of a generic version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


march ecosystem

March 1, 2021 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

February 22, 2021 | Product Awareness

Dr. Reddy's Laboratories announces the launch of Capecitabine Tablets, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


press release

February 18, 2021 | Press Releases

Dr. Reddy's Laboratories announces the launch of Vigabatrin Tablets, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr reddy

January 8, 2021 | Product Awareness

You make Promises. We help you keep them.

Posted by RXinsider Staff RXinsider Staff


press release

December 23, 2020 | Press Releases

Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS™ (favipiravir) Tablets for the treatment of COVID-19 under Health Canada’s Interim Order

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

October 12, 2020 | Product Awareness

Dr. Reddy's Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

October 9, 2020 | Product Awareness

Dr. Reddy's announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

October 5, 2020 | Product Awareness

Dr. Reddy's Laboratories announces the launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

September 28, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

September 23, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

September 18, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Spotlights by RXinsider

September 11, 2020 | SPOTLIGHTS

Injectable Medicines Through World-Class Capabilities - Dr. Reddy's Laboratories

Posted by Martha Jones Martha Jones


Pharmacy Press Release

September 10, 2020 | Press Releases

Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

September 3, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr. Reddy's

July 29, 2020 | Product Awareness

We are Committed to Making Affordable and Innovative Injectable Medicines - Dr. Reddy's [VIDEO]

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

June 19, 2020 | Press Releases

Dr. Reddy’s Laboratories Completes the Acquisition of Select Business Divisions of Wockhardt

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

June 17, 2020 | Press Releases

Dr. Reddy's Laboratories Announces the Launch of Colchicine Tablets USP, 0.6 mg in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


Dr. Reddys

May 29, 2020 | Product Awareness

We are Committed to Making Affordable and Innovative Injectable Medicines - Dr. Reddy's

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

May 12, 2020 | Press Releases

Dr. Reddy's Laboratories received approval for their NDA, ELYXYB™ (celecoxib oral solution) 25 mg/mL, in the U.S.

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

May 8, 2020 | Press Releases

Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market

Posted by RXinsider Staff RXinsider Staff


march ecosystem

March 20, 2020 | Product Awareness

March Market Leaders: Pharmaceutical Manufacturers

Posted by RXinsider Staff RXinsider Staff


Pharmacy Press Release

March 20, 2020 | Press Releases

Dr. Reddy's Launches 1st Generic of Geodon for Injection

Posted by RXinsider Staff RXinsider Staff

Today's Posts